Free Trial
NASDAQ:UTRS

Minerva Surgical (UTRS) Stock Price, News & Analysis

Minerva Surgical logo

About Minerva Surgical Stock (NASDAQ:UTRS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
656 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Minerva Surgical, Inc. is a medical device company focused on women’s health. The company develops and commercializes products designed to diagnose and treat abnormal uterine bleeding and other common gynecological conditions, with an emphasis on minimally invasive procedures that may be performed in office or outpatient settings.

Its product portfolio has included the Minerva ES Endometrial Ablation System, which uses controlled energy to treat heavy menstrual bleeding; the Genesys HTA System, a hysteroscopic thermal endometrial ablation device; and the Symphion System, which is designed for hysteroscopic tissue removal, including the treatment of uterine fibroids and polyps. Minerva has also offered products supporting gynecological procedures such as cervical dilation and uterine access.

Founded in 2008 and headquartered in Redwood City, California, Minerva Surgical has marketed its products primarily through the U.S. gynecological care market, with distribution and commercial activities also extending to selected international markets. Its products are intended for use by gynecologists and other qualified healthcare professionals in hospitals, ambulatory surgery centers and office-based settings.

AI Generated. May Contain Errors.

Receive UTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTRS Stock News Headlines

Minerva Surgical Inc.
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
Minerva Surgical Inc UTRS
Minerva Surgical Reports Third Quarter 2023 Financial Results
See More Headlines

UTRS Stock Analysis - Frequently Asked Questions

Minerva Surgical, Inc. (NASDAQ:UTRS) posted its earnings results on Wednesday, December, 1st. The company reported ($23.00) EPS for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The business earned $12.51 million during the quarter, compared to the consensus estimate of $12.23 million.

Minerva Surgical shares reverse split before market open on Monday, October 2nd 2023.The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Minerva Surgical (UTRS) raised $100 million in an initial public offering (IPO) on Friday, October 22nd 2021. The company issued 6,250,000 shares at $15.00-$17.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Minerva Surgical investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
12/01/2021
Today
10/11/2026
Next Earnings (Estimated)
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:UTRS
CIK
1452965
Fax
N/A
Employees
174
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$51.69 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,880,000
Free Float
8,124,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
2.37

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:UTRS) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners